DRIO DarioHealth Inc Gross Profitability

Corporate emblem and logo of DarioHealth Corp (DRIO)

DarioHealth Corp. maintains a pristine image due to high trust among digital medicine users. The company develops its software internally while outsourcing the production of glucometers to third-party vendors. This gross margin chart confirms the efficiency of this model, with the indicator fixed at 57.90. Lifetime subscriptions for consumables from patients with hypertension and diabetes ensure a stable cash flow.

mydario.com (DRIO) - Gross Margin from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for mydario.com (DRIO)

- market value and analyst target forecast:
Basic company analysis:DRIO DarioHealth Corp
Manufactured products of DarioHealth Corp.

The DarioHealth Corp. (DRIO) digital disease management ecosystem enables the company to maintain stable subscription pricing, which directly impacts the efficiency of its operating model. By analyzing gross margin distribution, an investor can see the portion of revenue remaining after direct production costs, where any downward trend signals rising expenses and a reduction in the company's capital financial cushion.